The impact of human aged bone marrow niche on human hematopoietic stem cell function

This project aims to investigate how aging alters the human bone marrow niche and its impact on hematopoietic stem cell function to improve understanding and outcomes in elderly hematopoiesis.

Subsidie
€ 1.500.000
2025

Projectdetails

Introduction

In humans, aging of the hematopoietic system is associated with anemia, impaired immune responses, and increased frequency of myeloid malignancies. The hematopoietic system is maintained by hematopoietic stem cells (HSCs). HSCs reside in the bone marrow (BM) within specialized niches, where they self-renew and differentiate to produce all blood and immune cells.

Clinical Implications

In the clinical setting of BM transplantation, HSCs from older donors result in a reduced transplantation success, with a worse level of engraftment and higher overall mortality. This demonstrates that there is a reduction in the function of aged human HSCs (hHSCs). Causes of this impaired hHSC function with age still remain unclear.

Importance of Research

Therefore, it is of great importance to uncover and subsequently target factors that contribute to hHSC aging in order to attenuate impaired hematopoiesis in the elderly. Due to the lack of meaningful human BM (hBM) niche models in the aging field, the current understanding of how extrinsic changes (stemming from the aged hBM niche) contribute to the aging of hHSC is far less advanced compared to the knowledge of the contribution of cell-intrinsic changes.

Proposal Focus

Thus, this proposal focuses on providing a significant understanding of age-associated changes within the hBM niche and their contribution to the aging of hHSCs using an aging-centered hBM niche model. Transplantation of young BM hHSCs into this advanced niche model revealed that an aged hBM niche confers aging on young hHSCs.

Research Questions

To this end, the target of the proposal is to address the following questions:

  1. How does aging affect the cellular and molecular composition of the hBM niche?
  2. To which extent does an aged hBM niche affect aging of hHSCs?
  3. What are the underlying mechanisms that confer an age-like function on hHSCs?

Challenges Addressed

MANAGE HSC addresses both technological and conceptual challenges in studying the role of the hBM niche in regulating hHSC function in the context of normal hematopoiesis and aging.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.500.000
Totale projectbegroting€ 1.500.000

Tijdlijn

Startdatum1-1-2025
Einddatum31-12-2029
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • UNIVERSITAET ULMpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Starting...

What does your blood remember? The memory of hematopoietic stem cells.

This project aims to investigate how hematopoietic stem cells develop adaptive memory to environmental stress, enhancing blood cell responses and improving transplantation strategies.

€ 2.500.000
ERC Starting...

Cell size as driver of stem cell aging and cancer

This project aims to investigate how cellular enlargement affects stem cell function and aging, potentially linking size to rejuvenation and cancer development, using mouse models for insights.

€ 1.500.000
ERC Consolid...

The Interplay of Aging, Immune Signaling and Stem Cell Function

This project aims to investigate how immune environment changes contribute to muscle stem cell dysfunction and regenerative decline in aging, with the goal of improving stem cell therapies.

€ 1.998.843
ERC Starting...

How is blood (re-)made? Regeneration of human hematopoietic stem cells after transplantation

RESTART aims to enhance survival in pediatric HSCT by using multiomics to characterize human HSPC regeneration and identify predictors of adverse outcomes.

€ 1.500.000
ERC Starting...

Unmasking the dynamic influence of the hematopoietic niche as an oncogenic path to myeloid neoplasms evolution

This project aims to explore hematopoietic-niche interactions across myeloid neoplasm stages to develop innovative therapies that prevent acute myeloid leukemia and improve patient outcomes.

€ 1.911.428

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Exploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application

This project aims to innovate hematopoietic stem cell identification and engineering through advanced culture techniques and multiomics profiling, enhancing gene therapy for blood disorders and cancer.

€ 3.797.562